INMDInmode Ltd
−1.8% today · −9.1% over a year
10/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 95% of the instruments we score
Stability: among the best of its peers; priced lower than most peers. No dividend.
Inmode Ltd (INMD) valuation against sector peers: P/E 9.0 (sector median 25.7), P/B 1.2, EV/EBIT 5.3, free-cash-flow yield 10.0%, P/S 2.3.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | INMD | Sector median | vs median |
|---|---|---|---|
| P/E | 9.0 | 25.7 · n=26 | 65% below |
| P/B | 1.2 | 3.6 · n=45 | 66% below |
| P/S | 2.3 | 4.7 · n=40 | 52% below |
| EV/EBIT | 5.3 | 22.6 · n=28 | 76% below |
| Free-cash-flow yield | 10.0% | 3.8% · n=39 | 167% above |
| Dividend yield | 0.00% | 0.19% · n=99 | 100% below |
| Return on equity | 13.5% | 5.2% · n=56 | 160% above |
| Return on invested capital | 15.6% | 6.5% · n=47 | 141% above |
| Gross margin | 78.5% | 70.2% · n=39 | 12% above |
| Net debt / EBITDA | −4.49 | 2.08 · n=25 | 316% below |
Value factor: 96 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| NOVNNovartis AG | 22.4 | 6.8 | 18.7 | 5.6% | 2.8% | 10/10 |
|---|---|---|---|---|---|---|
| NVSNovartis AG | 22.3 | 6.8 | 18.7 | 5.6% | 2.4% | 10/10 |
| AZNAstraZeneca PLC | 28.3 | 5.9 | 22.8 | 4.1% | 1.2% | 5/10 |
| AZNAstraZeneca plc | 28.3 | 5.9 | 22.8 | 4.1% | 1.7% | 6/10 |
| NVONovo Nordisk A/S | 11.8 | 6.2 | 10.3 | 4.9% | 4.6% | 7/10 |
| SNYSanofi | 13.4 | 1.5 | 18.2 | 6.9% | 4.3% | 7/10 |
| SANSanofi SA | 13.4 | 1.5 | 18.2 | 6.9% | 4.8% | 9/10 |
| GSKGSK plc | 14.5 | 5.1 | 11.8 | 7.7% | 3.5% | 9/10 |
| TEVATeva Pharmaceutical Industries Limited | 97.8 | 6.2 | 43.3 | 2.5% | 0.0% | 6/10 |
| ALCAlcon AG | 37.5 | 1.7 | 29.3 | 4.7% | 0.5% | 5/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 10 Feb 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.